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In the central nervous system, oligodendrocytes provide support to axons thanks to the production of a myelin 
sheath. During their maturation oligodendroglial precursors (OPCs) follow a very precise differentiation 
program, finely orchestrated by transcription factors, epigenetic factors and microRNAs, a class of small non-
coding RNAs involved in post-transcriptional regulation. Any alterations in this program can potentially 
contribute to dysregulated myelination, impaired remyelination and neurodegenerative conditions, as it happens 
in multiple sclerosis. 
Recently, we identified miR-125a-3p as a new actor of oligodendroglial maturation, that could also be involved 
in the pathological consequences of multiple sclerosis, showing that its over-expression impairs, whereas its 
silencing promotes, oligodendrocyte maturation (Lecca et al., Sci Rep, 2016). 
To shed light on the mechanism underlying this effect, we performed a microarray analysis on OPCs after miR-
125a-3p over-expression. This analysis suggested that miR-125a-3p is indeed involved in the regulation of 
biological processes important for OPC maturation, such as cell-cell interaction and morphological 
differentiation. To evaluate whether miR-125a-3p modulation may influence the progression of remyelination in 
vivo, we overexpressed the miR-125a-3p by lentiviral approach in a focal lysolecithin-mediated demyelinating 
lesion in the subcortical white matter of adult mice. Interestingly, also in this case, we found that miRNA-
overexpressing OPCs persisted in an immature (i.e. PDGRα+/NG2+) state. 
Moreover, we found that miR-125a-3p levels are altered in both brain active lesions and cerebrospinal fluid of 
multiple sclerosis patients, suggesting that it could be a potential biomarker of disease. 
The identification of a new miRNA modulating oligodendrocyte differentiation provides new findings about the 
complex regulation of myelination processes and we postulate that an antago-miRNA for miR-125a-3p may help 
promoting oligodendrocyte maturation in diseases characterized by impaired myelin repair. Sponsored by 
Fondazione Italiana Sclerosi Multipla 2013/R-1 project to MPA and by Fondazione Cariplo, grant n° 2014-1207 
to DL. 
 
